Definitive Healthcare Reports Second-Quarter 2026 Financial Results as AI Innovation and Customer Wins Support Growth Strategy
Definitive Healthcare Corp., a provider of healthcare market data and analytics, has announced its financial results for the second quarter ended June 30, 2026, highlighting continued progress in customer retention, new business wins, artificial intelligence innovation and cash generation despite lower year-over-year revenue.
The company reported second-quarter revenue of $55.2 million, representing a 9% decline from the $60.8 million reported during the same period in 2025. While revenue remained under pressure, Definitive Healthcare continued to generate positive operating cash flow and adjusted profitability, while management emphasized that the business performed within or above its guidance ranges.
The quarter also marked another period of investment in the company’s growth priorities, including the launch of Turbo, its new AI-powered healthcare intelligence platform. Management views the product as an important milestone in its innovation strategy and an opportunity to strengthen the company’s position in the healthcare data and analytics market.
CEO Kevin Coop said the company delivered another quarter that was in line with or above its guidance expectations, reflecting continued financial discipline alongside targeted investments designed to support future growth.
Revenue Declines 9% Year Over Year
Definitive Healthcare generated $55.2 million in revenue during the second quarter of 2026, compared with $60.8 million in the second quarter of 2025.
The 9% year-over-year decline illustrates the challenging environment the company continues to navigate. However, management’s commentary indicates that the business is focusing on improving customer retention, winning back former customers and increasing adoption of its data and analytics offerings.
For a company operating in healthcare market intelligence, revenue performance is closely connected to customer retention and expansion. Definitive Healthcare provides data, insights and integrations that support important commercial and operational decisions across healthcare organizations.
Management said the company experienced a second consecutive quarter of year-over-year improvement in net dollar retention, an important indicator of customer engagement and recurring revenue performance.
Improvement in net dollar retention can signal that existing customers are increasingly renewing, expanding or adopting additional products, providing an important foundation for future growth.
Net Loss Improves From Prior Year
Definitive Healthcare reported a net loss of $7.5 million for the second quarter of 2026, equivalent to 14% of revenue.
That compares with a net loss of $9.3 million, or 15% of revenue, in the second quarter of 2025.
Although the company remained in a net loss position on a GAAP basis, the year-over-year improvement in the loss as a percentage of revenue indicates continued attention to cost management and operating efficiency.
The reduction in the reported net loss comes as Definitive Healthcare continues to balance investments in technology and growth initiatives with efforts to maintain profitability.
The company’s management has emphasized disciplined execution, suggesting that investments are being directed toward areas expected to generate long-term value rather than broad-based spending increases.
Adjusted Net Income Remains Positive
On an adjusted basis, Definitive Healthcare reported adjusted net income of $7.5 million in the second quarter.
This compares with adjusted net income of $9.7 million in the same quarter of 2025.
The decline in adjusted net income reflects the lower revenue base, although the company continued to generate positive adjusted earnings.
Adjusted financial measures provide management and investors with another perspective on the underlying performance of the business by excluding certain items that may affect GAAP results.
The continued generation of adjusted net income demonstrates that Definitive Healthcare’s underlying operations remain profitable despite the company’s current revenue challenges.
Adjusted EBITDA Reaches $14.6 Million
Definitive Healthcare reported adjusted EBITDA of $14.6 million for the quarter, compared with $18.7 million in the second quarter of 2025.
Adjusted EBITDA represented 26% of revenue, compared with a margin of 31% in the prior-year period.
The lower EBITDA margin reflects the impact of the company’s reduced revenue as well as continued investment in its growth priorities.
Nevertheless, a 26% adjusted EBITDA margin indicates that the company continues to generate substantial earnings before interest, taxes, depreciation and amortization on an adjusted basis.
Maintaining strong profitability while investing in new products and technology is an important part of Definitive Healthcare’s strategy as it works to return to more sustainable revenue growth.
Strong Cash Generation
Cash generation remained a key positive feature of Definitive Healthcare’s second-quarter performance.
The company generated $11.5 million in cash flow from operations during the quarter.
It also reported $11.6 million in unlevered free cash flow.
Strong cash generation can provide a company with additional financial flexibility to invest in products, technology and customer initiatives while managing its broader financial obligations.
For Definitive Healthcare, cash flow is particularly important as the company continues to invest in its data infrastructure and AI capabilities.
The ability to generate cash internally can reduce dependence on external financing and provide management with greater flexibility when allocating resources toward strategic priorities.
CEO Highlights Customer Retention Improvements
Kevin Coop, CEO of Definitive Healthcare, said the company’s second-quarter results reflected continued discipline while maintaining targeted investment in growth initiatives.
He highlighted the improvement in net dollar retention as one of the positive developments during the quarter.
The company recorded a second consecutive quarter of year-over-year improvement in this metric, suggesting that customer relationships may be strengthening after a period of pressure.
Coop also highlighted win-back momentum across Definitive Healthcare’s end markets, pointing to examples in which former customers returned to the company’s platform after evaluating lower-cost alternatives.
According to management, these customer decisions reinforce the importance of data quality and service in the healthcare analytics market.
Significant Enterprise Customer Win-Back
One of the company’s notable second-quarter customer wins involved a diversified-business customer that returned to Definitive Healthcare through a six-figure, three-year enterprise agreement.
The win is significant because it demonstrates the company’s ability to regain customers who previously moved away from its products.
Management said the experience reinforced a recurring trend in the market: some customers may initially choose lower-cost alternatives, only to determine that the value of more comprehensive or higher-quality data outweighs the initial savings.
Healthcare organizations rely on accurate data for a wide range of commercial and operational decisions. When data quality is insufficient, organizations can face additional costs associated with inaccurate targeting, inefficient workflows or poor decision-making.
Definitive Healthcare believes its focus on data quality and customer service provides a competitive advantage in this environment.
The customer win-back therefore represents more than an individual contract. It supports management’s broader argument that the company’s data quality remains an important differentiator.
Expansion Within Population Intelligence
Definitive Healthcare also reported expansion involving a long-standing population-intelligence customer.
The customer initially began with a test before expanding into a total activation commitment worth several hundred thousand dollars.
This expansion demonstrates another important component of Definitive Healthcare’s strategy: increasing usage among existing customers.
Rather than relying solely on acquiring new customers, the company is seeking to increase adoption and spending within its existing customer base.
Management also noted that activation growth is being driven not only by direct customers but increasingly through its agency ecosystem.
This creates another potential channel for expansion because agencies can support multiple healthcare organizations and potentially broaden the reach of Definitive Healthcare’s data and intelligence solutions.
Turbo Brings AI Into Healthcare Intelligence
One of the most significant developments during the second quarter was the launch of Turbo, Definitive Healthcare’s new AI-powered healthcare intelligence platform.
The company described Turbo as an important milestone in its innovation strategy.
Artificial intelligence is rapidly changing the healthcare data and analytics industry. Organizations are increasingly looking for technologies capable of processing large volumes of information, identifying relevant insights and helping users make decisions more efficiently.
Definitive Healthcare’s launch of Turbo represents an effort to incorporate AI directly into its healthcare intelligence offerings.
The platform is expected to build on the company’s existing data and analytics capabilities while using AI to make healthcare intelligence more accessible and actionable for customers.
For Definitive Healthcare, combining AI with proprietary healthcare data could provide opportunities to improve the way customers search for information, analyze markets and identify relevant business opportunities.
Data Quality Remains Central to Strategy
Despite the growing importance of AI, Definitive Healthcare continues to emphasize the quality of its underlying data.
AI-powered tools are only as useful as the information they process. In healthcare, where data can be complex, fragmented and constantly changing, maintaining accurate and reliable datasets is particularly important.
The company therefore views data quality as a central component of its competitive strategy.
Management believes that customers who initially select lower-cost alternatives may eventually return when they discover that lower-quality data can negatively affect business outcomes.
The reported six-figure win-back agreement provides an example of this dynamic.
By combining high-quality healthcare data with analytics, integrations and AI capabilities, Definitive Healthcare aims to provide customers with a more comprehensive intelligence platform.
Focus on Customer Success
Customer success remains another major component of the company’s strategy.
Definitive Healthcare’s management believes that stronger customer relationships can contribute to improved retention and expansion.
The company’s recent customer wins demonstrate two different pathways to growth: winning back customers who previously left and increasing spending among existing customers.
Both approaches can complement new customer acquisition.
Improving customer retention is particularly important for recurring-revenue businesses because retaining an existing customer can help provide a more predictable revenue base.
The company’s consecutive quarters of year-over-year improvement in net dollar retention suggest that management’s efforts may be beginning to stabilize customer relationships.
Returning to Sustainable Growth
Despite the second-quarter revenue decline, management remains focused on returning Definitive Healthcare to sustained and predictable growth.
The company is pursuing this objective through several interconnected priorities: improving data quality, strengthening customer success, increasing adoption, expanding its agency ecosystem and investing in AI-powered products.
The strategy is designed to create a stronger foundation for future revenue growth rather than relying on short-term measures.
The launch of Turbo could become an important part of that strategy if the platform drives increased customer engagement and creates new opportunities for expansion.
At the same time, the company’s continued focus on profitability and cash flow provides financial support for its growth investments.
Balancing Investment With Financial Discipline
Definitive Healthcare’s second-quarter results illustrate the balance the company is attempting to achieve between investing for future growth and maintaining financial discipline.
Revenue declined 9% year over year, while adjusted EBITDA and adjusted net income also decreased. However, the company continued to generate positive operating cash flow and unlevered free cash flow.
Management’s emphasis on targeted investment suggests that spending is being directed toward specific strategic priorities, particularly technology, AI and customer success.
This approach could help the company preserve profitability while building new capabilities.
Outlook for Definitive Healthcare
Definitive Healthcare enters the second half of 2026 focused on strengthening its position in healthcare market data and analytics.
The second quarter provided several signals that management views as encouraging, including improving net dollar retention, customer win-backs, expansion among existing customers and the launch of Turbo.
At the same time, the 9% revenue decline demonstrates that the company still faces challenges in returning to top-line growth.
The path forward will depend on the company’s ability to convert improved customer retention and product adoption into sustainable revenue expansion.
Its AI strategy could also play an increasingly important role as healthcare organizations seek more sophisticated tools for analyzing data and generating actionable intelligence.
With $11.5 million in operating cash flow and $11.6 million in unlevered free cash flow during the quarter, Definitive Healthcare retains a meaningful ability to fund its operations and strategic initiatives.
Overall, the second-quarter results show a company continuing to navigate a period of revenue pressure while investing in the technologies and customer relationships it believes can support its next phase of growth. The combination of improving net dollar retention, customer win-back activity, expansion opportunities and the introduction of Turbo provides several potential avenues for recovery.
As Definitive Healthcare continues to focus on data quality, customer success and AI-powered healthcare intelligence, the company’s ability to translate these initiatives into stronger recurring revenue growth will remain a key measure of its progress in the quarters ahead.
Source link: https://ir.definitivehc.com/
